https://www.selleckchem.com/pr....oducts/pimicotinib.h
i. 0·52 to 1·59; P = 0·736) or severe complications (odds ratio 0·66, 0·29 to 1·53; P = 0·329). Skeletal muscle index decreased during neoadjuvant therapy but was not associated with postoperative complications. Skeletal muscle index decreased during neoadjuvant therapy but was not associated with postoperative complications. To understand the epidemiology, current treatment and disease burden of systemic lupus erythematosus (SLE) in the Asia Pacific region (APAC). A targeted literature review of published evidence on SLE in APAC wa
Like
Comment
Share
